MorphoSys AG (WBO:MOR)
€ 66.55 -1.1 (-1.63%) Market Cap: 2.49 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 50.61 GF Score: 59/100

MorphoSys AG at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 01:15AM GMT
Release Date Price: €15.27 (+3.07%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Great. Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the MorphoSys presentation. And you're going to hear from MorphoSys' CEO, Jean-Paul Kress.

And we're going to have about a 20-minute presentation, and then we're going to have about 20 minutes of Q&A. And you'll be able to ask questions either by raising your hand and we can pass you a microphone, or you can use the JPMorgan app that you're probably now quite familiar with, and I can ask your question for you.

So with that said, thanks very much for joining us today, Jean-Paul.

Jean;Paul Kress
MorphoSys AG - Chairman of Management Board, MD & CEO

Thank you, James. Thank you very much. Pleasure to be here in person to share with you our progress at MorphoSys and our many opportunities. I will start by showing the forward-looking statements slide, which I'm not sure if it works. Oops, that's the thing.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot